BigHat Biosciences
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
$75MSeries C
ParticipantS
S32
Activity from announced rounds
Activity in this selectionUnited States · Oct 23, 2026 · Sep 24, 2026
S32, formerly identified as Section 32, is a venture firm whose stated focus includes AI, computational biology, physical AI, infrastructure, cybersecurity and enterprise technology.
Recorded funding activity
The RoundOS history includes Basecamp’s biological models, Snorkel’s training-data systems, Ema’s enterprise agents and Network Bio’s tissue-data models. These are covered financing announcements rather than a complete portfolio.
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $75M 1 disclosed · full round size, not this investor’s share